《大行報告》中金上調攜程-S(09961.HK)今明兩年盈測 維持「跑贏行業」
中金發表報告指,暑期旺季推動下,攜程-S(09961.HK)(TCOM.US)第三季毛收入按年增99%至138億元,基本符合市場預期;非通用準則淨利潤為49億元,大幅超出市場預期49%,主要因為營銷費用投入低於預期。
該行基本維持對攜程全年收入不變,考慮到明年內地高基數下增長承壓,下調明年收入預測1.2%至513億元,同時考慮到公司利潤超預期,分別上調今明年非通用準則淨利潤預測16%和6%至119億元和119億元。該行關注跨境需求釋放,Trip.com或成新增長引擎,維持「跑贏行業」評級,匯率假設微調,維持美股和港股目標價50美元和387.5港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.